Thomas Hanslik Selected Research

Adrenal Cortex Hormones (Corticosteroids)

1/2023	Influenza-like illness in individuals treated with immunosuppressants, biologics, and/or systemic corticosteroids for autoimmune or chronic inflammatory disease: A crowdsourced cohort study, France, 2017-2018.
9/2016	Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus: Case report and brief review of other published cases.
9/2013	Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study.
10/2009	[Description of French general practitioners' practices regarding long term systemic corticosteroid therapy-associated measures].
12/2007	Vasculitides associated with malignancies: analysis of sixty patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Hanslik Research Topics

Disease

19	Human Influenza (Influenza) 01/2023 - 10/2009
12	Infections 12/2023 - 05/2005
3	Hemorrhage 07/2023 - 01/2004
3	COVID-19 01/2022 - 01/2021
3	Herpes Zoster 01/2022 - 02/2012
3	Vasculitis (Vasculitides) 10/2017 - 02/2007
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2023 - 02/2007
2	Chickenpox 03/2022 - 09/2003
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2019
2	Gastroenteritis 11/2019 - 10/2013
2	Neoplasms (Cancer) 12/2014 - 12/2007
2	Systemic Scleroderma (Systemic Sclerosis) 12/2014 - 12/2011
2	Autoimmune Diseases (Autoimmune Disease) 08/2014 - 03/2011
2	Pain (Aches) 04/2013 - 02/2012
1	Mumps 12/2023
1	Atrial Fibrillation 07/2023
1	Capillary Leak Syndrome 11/2022
1	Paraproteinemias (Monoclonal Gammopathy) 11/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Hip Fractures (Intertrochanteric Fractures) 01/2021
1	Osteoporotic Fractures 01/2021
1	Nasopharyngitis 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Bronchitis 01/2020
1	Otitis Media with Effusion 01/2020
1	Cognitive Dysfunction 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Venous Thromboembolism 01/2019
1	Lyme Disease (Disease, Lyme) 01/2019
1	Dementia (Dementias) 01/2019
1	Immunoglobulin G4-Related Disease 10/2017
1	Urinary Tract Infections (Urinary Tract Infection) 02/2017
1	Sensorineural Hearing Loss 09/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2016
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 09/2016
1	Hearing Loss (Hearing Impairment) 09/2016
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2016
1	Thrombocytopenia (Thrombopenia) 09/2016
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 04/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2015
1	Tetanus 01/2015
1	Pulmonary Hypertension 12/2014
1	HIV Infections (HIV Infection) 08/2014

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 02/2009
6	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2017 - 03/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 12/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2011
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 12/2007
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2017 - 02/2007
3	AnticoagulantsIBA 07/2023 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2019 - 02/2012
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2021
2	AntibodiesIBA 07/2021 - 12/2014
2	Proton Pump InhibitorsIBA 11/2019 - 01/2019
2	Viral RNAIBA 01/2019 - 12/2015
2	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2015
1	AA amyloidosisIBA 12/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2023
1	Oxidants (Oxidizing Agents)IBA 11/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	CytokinesIBA 11/2023
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 07/2023
1	RivaroxabanIBA 07/2023
1	Anti-Arrhythmia AgentsIBA 07/2023
1	Cytochrome P-450 CYP3A InhibitorsIBA 07/2023
1	apixabanIBA 07/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2022
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022
1	ORALIT (ORS)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	BenzodiazepinesIBA 01/2020
1	Memantine (Namenda)FDA Link 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020
1	Nucleic AcidsIBA 06/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	1- (3,4- dihydroxyphenyl)- 2- (3- (4- carbamylphenyl)- 1- methylpropylamino)ethanolIBA 01/2019
1	AntipyreticsIBA 11/2017
1	CI 22IBA 10/2017
1	Antiphospholipid AntibodiesIBA 09/2016
1	AutoantibodiesIBA 09/2016
1	Immunologic Factors (Immunomodulators)IBA 12/2015
1	cyclo(Arg-Pro) (CI 4)IBA 01/2015
1	SolutionsIBA 01/2015
1	Neuraminidase (Sialidase)IBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 12/2014

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2003
1	Ambulatory Care (Outpatient Care) 01/2021
1	Emergency Treatment 09/2016
1	Duration of Therapy 04/2016
1	Highly Active Antiretroviral Therapy (HAART) 08/2014